Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
11/2003
11/05/2003EP1359147A1 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and processes for making the same
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642020 Process for preparing cephalosporin derivatives
10/2003
10/31/2003WO2002085909A1 9-deazaguanine derivatives as inhibitors of gsk-3
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089440A1 Polymorph of ascomycin derivative
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003045319A3 Targeted therapeutics and uses thereof
10/30/2003US20030203931 Polymorph of a pharmaceutical
10/30/2003US20030203929 Microtubule stabilizing compounds
10/30/2003US20030203903 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
10/30/2003CA2482717A1 Polymorph of ascomycin derivative
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP0779281B1 Isoxazoles
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087068A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003WO2003043960A3 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
10/23/2003WO2003016248A3 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003WO2001036048A8 Phorboxazole derivatives for treating cancer
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199541 topical bactericides and disinfectants for surgical instruments; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen; (SML pat indexing merged to app)
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199537 Macrocyclic lactone useful in immunosuppressant therapy
10/23/2003US20030199531 Biodegradation-resistant mimics of pentapeptide tyrosine-isoleucine-glycine-serine-arginine (YIGSR) binding site for laminin binding protein
10/23/2003US20030199525 Kinase inhibitors
10/23/2003CA2482207A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
10/23/2003CA2448525A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/22/2003EP1354020A1 Novel red fluorescent material and organic electroluminescent device containing same
10/22/2003EP1353929A2 Streptogramin derivatives preparation thereof and compositions containing same
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1131073B1 Use of staurosporine derivatives for treating ocular neovascular diseases
10/22/2003EP1097136B1 Process for the preparation of an indole derivative
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1125073C Process for preparing (-) pyridobenzoxazine carboxylic acid derviatives
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635647 Decahydro-isoquinolines
10/21/2003CA2237401C Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
10/16/2003WO2003084965A1 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084960A1 Cyclic compounds and the use thereof as light absorbers, light emitters, or complex ligands
10/16/2003WO2003050064A3 Mitotic kinesin inhibitors
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003CA2481463A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/15/2003EP1351681A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/15/2003CN1449384A Novel ester or amide derivatives
10/15/2003CN1448393A Novel dioxomorpholine for antiendoparasite
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124264C Process for preparing quinolone- and naphthyridonecarboxylic acids and esters thereof
10/15/2003CN1124135C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/14/2003US6632948 Azetidine derivative and process for preparation thereof
10/14/2003US6632818 Inhibitors of prenyl-protein transferase
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/09/2003WO2003082878A1 Substituted amino isoxazoline derivatives and their use as anti-depressants.
10/09/2003WO2003082877A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/09/2003WO2003082836A1 New dioxomorpholines for combating endoparasites
10/09/2003WO2003082832A2 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003WO2003082830A1 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082192A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191305 Reacting a 16-sulphonyloxy substituted sterptogramin derivative with alkali metal cyanide, and reducing the compound obtained from the solution
10/09/2003US20030191148 Macrolides
10/09/2003US20030191143 Attenuation immunology response; antiproliferative agents; rheumatic diseases; hypotensive agents; antilipemic agents; anticholesterol agents
10/09/2003US20030191138 Indolo[2,1-b] quinazole-6,12-dione antimalarial compounds and methods of treating malaria therewith
10/09/2003US20030191123 2-amino-benzoxazinone derivatives for the treatment of obesity
10/09/2003US20030191106 Controlling gramnegative bacteria
10/09/2003US20030191074 Antibody therapy; immobilization
10/09/2003CA2480869A1 Anxiolytic agents with reduced sedative and ataxic effects
10/09/2003CA2479932A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
10/08/2003EP1350794A1 Process for preparing substance gm-95
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349839A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
10/08/2003EP1070068B1 Granulatimide derivatives for use in cancer treatment
10/08/2003EP0923556B1 An asymmetric conjugate addition reaction
10/08/2003CN1446815A Compound of benzoindole spiroxaxine as well as its synthetic method and usage
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/07/2003US6630470 G-CSF mimetics
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080626A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080595A1 Blue 3h-naphtho-[2,1-b]-pyran derivatives and use thereof
10/02/2003WO2003080545A2 Substituted phenylacetic acids
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 220